| Andreu et al., “Formation of Disulfide Bonds in Synthetic Peptides and Proteins”, Methods in Molecular Biology, vol. 35, (1994). |
| Arnone et al., “The DNA Binding Activity and the Dimerization Ability of the Thyroid Transcription . . . ”, J. Biological Chemistry, vol. 270, No. 20, 12048-12055, (1995). |
| Balcewicz-Sablinska et al., “Human Eosinophil Cytotoxicity-Enhancing Factor, II. Multiple Forms Synthesized by U937 Cells . . . ”, J. of Immunology 147, 2170-2174 (Oct. 1, 1991). |
| Bannister et al., “In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes”, Oncogene 6, 1243-1250 (1991). |
| Beckmann et al., “Preparation of chemically “mutated” aprotinin homologues by semisynthesis . . . ”, FEBS 1988—EJB 88 0141. |
| Bergstrand et al., “Stimuli-induced Superoxide Radical Generation In Vitro by Human Alveolar Macrophages from Smokers . . . ”, J. of Free Radicals in Biol. & Medicine, vol. 2, 119-127, (1986). |
| Bushweller et al., “Structural and Functional Characterization of the Mutant Escherichia coli Glutaredoxin . . . ”, Biochemistry, 31, 9288-9293; (1992). |
| Louis A. Carpino, “1-Hydroxy-7-azabenzotriazole. An Efficient Peptide Coupling Additive”, J. Am. Chem. Soc., 115, 4397-4398 (1993). |
| Chalmers et al., Pro-D-NMe-Amino Acid and D-Pro-NMe-Amino Acid. Simple, Efficient Reverse-Turn Constraints J. Amer. Chem. Soc., 117, 5927-5937; (1995). |
| Chen et al., “Costimulation of T cells for tumor immunity”, Immunology Today, 483, vol. 14, No. 10, (1993). |
| Civitareale et al., “Purification and characterization of thyroid transcription factor 2”, Biochem. J.,304, 981-985 (1994). |
| Clarke et al., “Identification of molecules involved in the “early pregnancy factor” phenomenon”, J. Reprod. Fert. 93, 525-539, (1991). |
| Deiss et al., “A Genetic Tool Used to Identify Thioredoxin as a Mediator of a Growth Inhibitory Signal” Science, vol. 252, 117-120 (Apr. 1991). |
| Verhoef et al., “Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification . . . ”, International Immunology, vol. 5, No. 12, 1589-1597 (1993). |
| Droge et al., “Functions of glutathione and glutathione disulfide in immunology and immunopathology”, Reviews, FASEB Journal vol. 8, 0892-6638/0008-1131, (1994). |
| Dryland et al., “Peptide Synthesis, Part 8, A System for Solid-phase Synthesis Under Low Pressure Continuous Flow Conditions”, J. Chem. Soc. Perkin Trans. 1 (1986). |
| Espinoza-Delgado et al., “Regulation of IL-2 Receptor Subunit Genes in Human Monocytes; Differential Effects of . . . ”, Journal of Immunology, vol. 149, No. 9, 2961-2968, No. 9 (1992). |
| Esposito et al., “DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells”, Biochimica et Biophysica Acta 1260, 308-314; (1995). |
| Flegel et al., “A Sensitive, General Method for Quantitative Monitoring of Continuous Flow Solid Phase Peptide Synthesis”, J. Chem. Soc., Chem. Commun., 536-538; (1990). |
| Grasso et al., “A synthetic peptide corresponding to hFSH-β-(81-95) has thioredoxin-like activity”, Molecular and Cellular Endocrinology, 78 163-170 (1991). |
| Grippo et al., “Proof that the Endogenous, Heat-stable Glucocorticoid Receptor-activating Factor Is Thioredoxin”, The Journal of Biological Chemistry, vol. 260, No. 1, 93-97, (1985). |
| Hansson et al., “T lymphocytes inhibit the vascular response to injury”, Proc. Natl. Acad. Sci. USA, vol. 88, 10530-10534, (1991). |
| Arne Holmgren, “Thioredoxin and Glutaredoxin Systems” The Journal of Biol. Chemistry, vol. 264, No. 24, 13963-13966, (1989). |
| Huang et al., “Characterization of the DNA-Binding Properties of the Early Growth Response-1 (Egr-1) Transcription . . . ”, DNA and Cell Biology, vol. 12, No. 3, 265-273, (1993). |
| John Jones, “The Chemical Synthesis of Peptides” Balliol College, Oxford (1991). |
| Kasafirek et al., “Amino Acids and Peptides, LXVI Synthesis of Ten Extended-chain Analogues of Lysine Vasopressin”, Collection Czechoslov. Chem. Commun. vol. 31, (1966). |
| David H. Katz, “The Allergic Phenotype: Manifestation of “Allergic Breakthrough” and Imbalance in Normal “Damping” of IgE Antibody Production”, Immunological Rev., vol. 41 (1978). |
| Khananshvili et al., “Positively Charged Cyclic Hexapeptides, Novel Blockers for the Cardiac Sarcolemma . . . ” The Journal of Biological Chemistry, vol. 270, No. 27, 16182-16188, (1995). |
| Knoepfel et al., “role of Zinc-Coordination and of the Glutathione Redox Couple in the Redox Susceptibility of Human Transcription Factor SP1”, Biochem. and Biophysical Res. Comm. vol. 201, No. 2, (1994). |
| McBride et al., “Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro”, Proc. Natl. Acad. Sci, 89,(1992). |
| Cornelis J. M. Melief, “Tumor Eradication by Adoptive Transfer of Cytotoxic T Lymphocytes”, Advances in Cancer Research ; 58:143-75 (1992). |
| Miele et al., “Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I”, Nature, vol. 335,726-730 (1988). |
| Mitomo et al., “Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro”, Gene, 145, 197-203,(1994). |
| Nicolas et al., “A Study of the Use of NH4I for the Reduction of Methionine Sulfoxide in Peptides containing Cysteine . . . ”, Tetrahedron, vol. 51, No. 19, 5701-5710, (1995). |
| Noiva et al., “Protein Disulfide Isomerase; A Multifunctional Protein Resident in the Lumen of the Endoplasmic Reticulum”, J. of Biological Chemistry, vol. 267, No. 6, 3553-3556, (1992). |
| Patel et al., “Sulfhydryl-Disulfide Modulation and the Role of Disulfide Oxidoreductases in Regulation of the Catalytic Activity . . . ”, Am. J. Respir. Cell Mol. Biol., vol. 13, 352-359, (1995). |
| Paul, “Representative Autoimmune Diseases and thier Animal Models”, Fundamental Immunology, 2nd Ed., 31:840-866, (1989). |
| Paupe, “Immunotherapy with an Oral Bacterial Extract (OM-85BV) for Upper Respiratory Infections”, Respiration, 58:150-154, (1991). |
| Pohl et al., “Cyclic disulfide analogues of the complement component C3a”, Int. J. Peptide Protein Res. 41, 362-375 (1993). |
| Radermecker et al., “Increase in the Number and the Phagocytic Function of Guinea Pig Pulmonary and Peritoneal Macrophages . . . ”, Int. J. Immunopharmac., vol. 10, No. 8, 913-917 (1988). |
| Rosenberg, “Immunotherapy of cancer using interleukin 2:” Immunology Today, vol. 9, No. 2, 58-62 (1988). |
| Roszman et al., “Modulation of T-cell function by gliomas”, Immunology Today, vol. 12, No. 10, 370-374 (1991). |
| Ruiz-Gayo et al., “Uteroglobin-like Peptide Cavities I. Synthesis of Antiparrallel and Parallel Dimers of Bis-Cysteine Peptides”, Tetrahedron Letters, vol. 29, No. 31, 3845-3848 (1988). |
| Salerno et al., “Covalent Modification with Concomitant Inactivation of the cAMP-dependent Protein Kinase by Affinity Labels . . . ” The Journal of Biological Chemistry, vol. 266, No. 18, 13043-13049 (1993). |
| Scheffer et al., “Effect of an Immunostimulatory Substance of Klebsiella pneumoniae on Inflammatory Responses . . . ”, Arzneim.-Forsch./Drug Res. 41 (II), 815-820 (1991). |
| Schulze-Osthoff et al., “Redox Signalling by Transcription Factors NF-κB and AP-1 in Lymphocytes” Biochemical Pharmacology, vol. 50, No. 6 735-741 (1995). |
| Sheppard et al., “Acid-labile resin linkage agents for use in solid phase peptide synthesis”, Int. J. Peptide Protein Res., 20, 455-467 (1982). |
| Shimotohno et al., “Identification of new gene products coded from X regions of human T-cell leukemia viruses”, Proc. Natl. Acad. Sci. USA vol. 82, 302-306 (1985). |
| Singh et al., “Application of Genetic Algorithms to Combinatorial Synthesis: A Computational Approach to Lead Identification and Lead Optimization”, J. Am. Chem. Soc., 118, 1669-1676, (1996). |
| Spinella et al., “Endothelin-receptor interactions Role of a putative sulfhydryl on the endothelin receptor” FEBS Letters, vol. 328, 82-88 (1993). |
| Spinella et al., “Design and synthesis of a specific endothelin 1 antagonist: Effects on pulmonary vasoconstriction”, Proc. Natl. Acad. Sci. USA, vol. 88, 7443-7446, (1991). |
| Stevenson, “Tumor vaccines”, The FASEB Journal, vol. 5, 2250-2257 (1991). |
| Van Wauwe et al., “Review Article on the biochemical Mode of Action of Levamisole: An Update”, Int. J. Immunopharmac., vol. 13, No. 1, 3-9 (1991). |
| Varela et al., “Second generation immune networks”, Immunology Today, vol. 12, No. 5, 159-166 (1991). |
| von Geldern et al., “Small Atrial Natriuretic Peptide Analogues: Design, Synthesis, and Structural Requirements for Guanylate Cyclase Activation”, J. Med. Chem. 35, 808-816 (1992). |
| Xanthoudakis et al., “The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains” Proc. Natl. Acad. Sci. USA, vol. 91, 23-27 (1994). |
| Xanthoudakis et al., “Analysis of c-Fos and c-Jun Redox-Dependent DNA Binding Activity”, Methods in Enzymology, vol. 234, 163-174 (1994). |
| Yao et al., “Activation of AP-1 and of a Nuclear Redox Factor, Ref-1, in the Response of HT29 Colon Cancer Cells to Hypoxia”, Molecular and Cellular Biology, vol., 14, No. 9, 5997-6003 (1994). |
| Yodoi et al., “Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation”, Immunology Today, vol. 13, No. 10, 405-411 (1992). |
| Zhang et al., “Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin”, Proc. Natl. Acad. Sci USA, vol. 88, 10252-10256 (1991). |
| International Search Report; International Application No. PCT/SE 96/00365; (Mar. 22, 1996). |
| International Search Report; International Application No. PCT/SE 95/01151; (Oct. 6, 1995). |
| International Search Report; International Application No. SE 95/00312; (Mar. 24, 1995). |
| International Search Report; PCT/JP95/00082; (May 2, 1995). |
Patent Grant
6228374
